Simplify Exchange Traded Funds · net assets $77.3M · 39 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 97.3% · DBT: 77.6% · RA: -74.9%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $1.34M | $0 | $0 |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $2.85M | $1.1M | $0 |
| Net realized gain (non-derivative) | $394K | $188K | $601K |
| Net unrealized appreciation (non-derivative) | $6.27M | $1.53M | $4.32M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Tenor | Investment grade | Non-investment grade |
|---|---|---|
| 3 months | $0 | $29.4 |
| 1 year | $0 | $9.75 |
| 5 years | $0 | $0 |
| 10 years | $0 | $0 |
| 30 years | $0 | $0 |
| Holding | Value | % of net assets |
|---|---|---|
| United States Of America - Bureau Of The Public Debt DBT | $59.3M | 76.77% |
| Plains Gp Holdings LP EC | $30.9M | 39.97% |
| Achieve Life Sciences Inc EC | $9.35M | 12.11% |
| Milestone Pharmaceuticals Inc EC | $4.49M | 5.81% |
| Achieve Life Sciences Inc EC | $3.41M | 4.42% |
| Delcath Systems Inc EC | $3.29M | 4.26% |
| Phathom Pharmaceuticals Inc EC | $2.7M | 3.50% |
| Corcept Therapeutics Inc EC | $2.3M | 2.98% |
| Abeona Therapeutics Inc EC | $2.13M | 2.76% |
| Celldex Therapeutics Inc EC | $1.98M | 2.56% |
| Kyverna Therapeutics Inc EC | $1.63M | 2.11% |
| Compass Pathways PLC EC | $1.62M | 2.09% |
| Leonabio Inc EC | $1.37M | 1.78% |
| Inventiva Sa EC | $1.18M | 1.53% |
| Aquestive Therapeutics Inc EC | $1.16M | 1.50% |
| Artiva Biotherapeutics Inc EC | $983K | 1.27% |
| Zevra Therapeutics Inc EC | $966K | 1.25% |
| Orchestra Biomed Holdings Inc EC | $947K | 1.23% |
| Palisade Bio Inc EC | $942K | 1.22% |
| Telesat Canada / Telesat LLC DBT | $895K | 1.16% |
| Ocular Therapeutix Inc EC | $796K | 1.03% |
| Achieve Life Scien Rts EC | $748K | 0.97% |
| Eyepoint Inc EC | $649K | 0.84% |
| Immunic Inc EC | $472K | 0.61% |
| Upstream Bio Inc EC | $430K | 0.56% |
| Akero Therapeutics Inc EC | $427K | 0.55% |
| Sab Biotherapeutics Inc EC | $409K | 0.53% |
| Ovid Therapeutics Inc EC | $260K | 0.34% |
| Altimmune Inc EC | $3.16K | 0.00% |
| Chinook Therapeutics Inc EC | $2K | 0.00% |
| Eiger Biopharmaceuticals Inc EC | $900 | 0.00% |
| Milestone Pharmace Wts EC | $1.84 | 0.00% |
| Jasper Therapeutic Wts EC | $0.61 | 0.00% |
| Wts - Tenaya Therapeutics EC | $0.56 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Morgan Stanley & Co. LLC RA | $-58.1M | -75.22% |
Loading...
